Pathobiology and Diagnosis of Multiple Myeloma
Objective:
To understand the role of the genetic changes and bone marrow microenvironment on the development, progression, and staging of multiple myeloma (MM).
Data Sources:
Peer-reviewed articles and clinical guidelines.
Conclusion:
The acquisition of genetic changes and the bone marrow microenvironment in which myeloma cells develop both influence the pathogenic potential of these malignant cells and is reflected in staging of the disease, risk of progression, and predicted response to treatment.
Implications For Nursing Practice:
Treatment of multiple myeloma is largely dependent on risk factors in which specific genetic alterations play a large role. Clinicians should be aware of these genetic changes and how they may influence the individual treatment plan for each patient.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...